<p>Mice (8 weeks old, 8 per group) were immunized twice by subcutaneous administration of an inactivated BTV-4 vaccine and inoculated with 10<sup>3</sup> PFUs of BTV-4,. (A) ELISA detection of antibodies to BTV-4 VP2 in serum of immunized and nonimmunized IFNAR<sup>(−/−)</sup> mice. Serum was collected two days before the challenge with BTV-4, and dilutions (1∶50 to 1∶1350) were analyzed by ELISA as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0005171#s4" target="_blank">Materials and Methods</a>. (B) Survival rates of immunized and nonimmunized IFNAR<sup>(−/−)</sup> mice after inoculation with BTV-4. The mice were observed every 24 h for 14 days. (C) Titers of BTV-4 recovered in blood of immunized and ...
<p>Results expressed as <i>C</i>t and transferred to negative (neg.) according to the cut-off <i>C</...
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
<p>Two weeks after the final immunization, splenocytes from mice injected intramuscularly with PBS, ...
<p>Mice (8 weeks old, 6 per group) were immunized twice by heterologous prime boost vaccination with...
<p>Mice (8 weeks old, 6 per group) were immunized twice by heterologous prime-boost vaccination with...
<p>(A) Mice (8 weeks old, 6 mice per group) were intravenously inoculated with 10-fold dilutions of ...
<p>The presence of antibodies specific of VP2, VP7, and NS1 in serum of immunized (A) and non-immuni...
<p>(A) Average group weights after challenge. (B) Survival rate of IFNAR<sup>−/−</sup> mice after BT...
<p>Mice were immunized twice with recombinant adenoviruses (group#1: Ad5-BTV-NS3 + Ad5-BTV-VP7 + Ad5...
<p>Results expressed as <i>C</i>t and transferred to negative (neg.) according to the cut-off <i>C</...
<p>(A) Titers of BTV-4 recovered in blood after intravenous infection with 10<sup>2</sup> (▪), 10<su...
<p>Groups of 6 IFNAR<sup>−/−</sup> mice were immunized three times at three weeks intervals with 5, ...
<p>Levels of IFN-γ ten days, short-term protection (STP), and twelve weeks, long-term protection (LT...
<p>Non-vaccinated control and MVA-VP2 vaccinated mice were challenged with AHSV-4. Survival rates (d...
IFNAR-/- mice aged 4–6 weeks old were immunized twice, two weeks apart with pVax1 or scMAYV-E using ...
<p>Results expressed as <i>C</i>t and transferred to negative (neg.) according to the cut-off <i>C</...
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
<p>Two weeks after the final immunization, splenocytes from mice injected intramuscularly with PBS, ...
<p>Mice (8 weeks old, 6 per group) were immunized twice by heterologous prime boost vaccination with...
<p>Mice (8 weeks old, 6 per group) were immunized twice by heterologous prime-boost vaccination with...
<p>(A) Mice (8 weeks old, 6 mice per group) were intravenously inoculated with 10-fold dilutions of ...
<p>The presence of antibodies specific of VP2, VP7, and NS1 in serum of immunized (A) and non-immuni...
<p>(A) Average group weights after challenge. (B) Survival rate of IFNAR<sup>−/−</sup> mice after BT...
<p>Mice were immunized twice with recombinant adenoviruses (group#1: Ad5-BTV-NS3 + Ad5-BTV-VP7 + Ad5...
<p>Results expressed as <i>C</i>t and transferred to negative (neg.) according to the cut-off <i>C</...
<p>(A) Titers of BTV-4 recovered in blood after intravenous infection with 10<sup>2</sup> (▪), 10<su...
<p>Groups of 6 IFNAR<sup>−/−</sup> mice were immunized three times at three weeks intervals with 5, ...
<p>Levels of IFN-γ ten days, short-term protection (STP), and twelve weeks, long-term protection (LT...
<p>Non-vaccinated control and MVA-VP2 vaccinated mice were challenged with AHSV-4. Survival rates (d...
IFNAR-/- mice aged 4–6 weeks old were immunized twice, two weeks apart with pVax1 or scMAYV-E using ...
<p>Results expressed as <i>C</i>t and transferred to negative (neg.) according to the cut-off <i>C</...
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
<p>Two weeks after the final immunization, splenocytes from mice injected intramuscularly with PBS, ...